CureVac’s vaccine disappoints in major trial, was poor match against 29 COVID variants
June 17, 2021 at 10:16 AM EDT
The global tally of confirmed cases of COVID-19 climbed above 177 million on Thursday, a day after disappointing news from CureVac with the German company saying its vaccine was only 47% effective in a late-stage clinical trial.
